AOD-9604

AOD-9604 (Anti-Obesity Drug) is a modified fragment of the C-terminus of Human Growth Hormone (HGH). It was specifically designed to stimulate fat metabolism (lipolysis) and inhibit the transformation of non-fatty foods into body fat (lipogenesis) without affecting blood sugar or IGF-1 levels.

Unlike standard HGH, AOD-9604 is highly selective for fat loss and does not cause the "HGH hunger" or water retention associated with other peptides.
________________________________________

1. Reconstitution & Dosage
AOD-9604 typically comes in 2mg or 5mg vials. It is very effective at low doses but requires strict timing.

• Reconstitution: Add 2ml of Bacteriostatic Water to a 5mg vial.
• The Concentration: This creates 2.5mg (2,500mcg) per 1ml.
• Syringe Measurement (U-100 Insulin Syringe):
o 12 units (0.12ml) = 300mcg (Standard daily dose)
o 20 units (0.20ml) = 500mcg (Maximum research dose)

Common Research Dosages:
• Standard Dose: 300mcg once daily.
• Frequency: 7 days a week (daily consistency is key for lipolysis).
________________________________________

2. The Cycle (Duration & Timing)
AOD-9604 is a "slow burner" and usually takes 4–8 weeks for visible changes in subcutaneous fat.

Parameter Recommendation
Cycle Length 12 to 16 Weeks
Timing Morning, immediately upon waking.
Fasting Window Crucial. No food for 2 hours before and 1 hour after injection.

The "Fasting Rule": Insulin is the "off switch" for AOD-9604. If you eat a meal (especially carbs) before or shortly after injecting, the peptide will be almost entirely neutralized.
________________________________________

3. Administration
• Subcutaneous (SubQ): Inject into the abdominal fat where you wish to see the most fat loss (local spot reduction is a common subject of research with AOD).
• Storage: Keep refrigerated. AOD-9604 is relatively stable, but once mixed, it should be used within 21–30 days.
________________________________________

4. Potential Side Effects

AOD-9604 is exceptionally well-tolerated and has a very high safety profile.
• Injection Site Redness: Mild itching or redness.
• Headache: Rare, usually occurs if the researcher is dehydrated.
• No Glucose Issues: Unlike HGH, it does not affect insulin sensitivity or blood sugar levels.
________________________________________

The "Shred" Stack
Researchers often stack AOD-9604 with Tesamorelin:
1. AOD-9604: Directly targets the breakdown of existing fat cells.
2. Tesamorelin: Reduces visceral (deep organ) fat and stimulates the body's natural GH production.
________________________________________

Quick Checklist for a 5mg Vial:
• At 300mcg/day: One vial lasts ~16 days.
• For a 12-week cycle: You will need roughly 5 to 6 vials.